Table 3.
Model | Genistein (µM) |
Duration | Effect | Mechanism | Ref |
---|---|---|---|---|---|
C57Bl/6J, 1 mo. old, STZ at 40mg/kg BW×5 d. | 250 mg/kg of diet | 2 wk | ↓ FBG, ↑ serum insulin, improved glucose tolerance, ↑ β cell mass & ↓ apoptosis in diabetics | Preservation of functional β cell mass | 56 |
C57BL/6 10-mo. old, STZ, 90 mg/kg BW | 250 mg/kg diet | 1 mo. in high-fat diet | ↓ FBG, ↑ serum insulin, & ↓ β cell apoptosis in diabetics | 84 | |
C57BL/6 8 wk old, STZ, 45 mg/kg BW×5d | 10 mg/kg BW via I.P. injection (3/wk) | 10 wk | ↓ FBG, ↓ proteinuria, albumin, nephrin & collagen excretions, ↓ oxidative stress | Increased renal phospho-Tyr and phospho- ERK/ERK | 81 |
♀ NOD mice, 8 wk old | 200 mg/kg diet | 9 wk | ↓ FBG, ↑ plasma insulin & C-peptide, ↓BUN, ↑ insulin in β-cells, ↓ gluconeogenis in liver, ↓ plasma FFA & triglyceride, & ↑ HDL | 89 | |
♂ Sprague Dawley, 7–8 wk old, alloxan-220 mg/kg BW | 30 mg/kg BW oral gavage | 4 wk post-alloxan injection | ↓ FBG, improved glucose tolerance, ↑ serum insulin, preserved islet mass | 80 | |
Isolated islets | 6.25, 12.5 and 25 µM | 24 h | 12.5 & 25 µM prevented apoptosis | 80 | |
♂ Sprague Dawley, (80–90 g), STZ, 50 mg/kg BW | 600 mg/kg diet (after STZ) | 3 wk | ↓ FBG and ↑ plasma insulin, ↓ HbA1C, ↓ hepatic antioxidant enzyme activities | 79 |